Wilson Sonsini Goodrich & Rosati is pleased to support the LaunchBio Larger Than Life Sciences Series: You Are What You Eat, The Microbiome is the Next Chapter in Drug Discovery. Scientists around the world agree—the microbiome is a critical and emerging tool in drug development for many disease areas and therapeutic modalities. From neuroscience to oncology and even soil science, the microbiome holds great promise for better patient outcomes. This field has exploded in the last 10-years providing opportunities for interdisciplinary collaborations and new startups. Industry experts will discuss what has been learned, where are we now and possibilities for the next generation of microbiome research looks like.
Lori Doyle
ldoyle@wsgr.com